Comparison of stable nitroxide, 3-substituted 2,2,5,5-tetramethylpyrrolidine-N-oxyls, with respect to protection from radiation, prevention of DNA damage, and distribution in mice

被引:16
作者
Anzai, K [1 ]
Ueno, M [1 ]
Yoshida, A [1 ]
Furuse, M [1 ]
Aung, W [1 ]
Nakanishi, I [1 ]
Moritake, T [1 ]
Takeshita, K [1 ]
Ikota, N [1 ]
机构
[1] Natl Inst Radiol Sci, Redox Regulat Res Grp, Inage Ku, Chiba 2638555, Japan
关键词
PROXYL; in vivo radioprotection; colony formation; redox potential; DNA base oxidation; DNA cleavage; in vivo distribution; free radical;
D O I
10.1016/j.freeradbiomed.2005.11.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
We compared three 3-substituted 2,2,5,5-tetramethylpyrrolidine-N-oxyls (PROXYLs): carbarnoyl-, methoxycarbonyl-, and hydroxymethyl-PROXYL (CM-, MC-, and HM-PROXYL, respectively) with respect to radioprotection, prevention of DNA damage, and in vivo distribution in mice. The PROXYLs provided protection to C3H mice against lethal X-irradiation (8 Gy) with the following order of magnitude, HM- > CM approximate to MC-PROXYL. In contrast, radioprotection at the cellular level assessed by the colony formation of leukemia cell line L5178Y showed no difference among them. The degree of protection from X ray-induced oxidation of DNA bases measured by the formation of 8-hydroxydeoxyguanosine in salmon DNA and the cleavage of DNA measured by electrophoresis of plasmid pBR322 DNA did not differ among the PROXYLs. Redox potentials were also similar for each. However, the blood concentration of the PROXYLs injected ip into the mice showed different maximum concentrations (HM- > CM- approximate to MC-PROXYL), although all reached a maximum at around 5-10 min and gradually decreased thereafter. Their concentration in bone marrow showed a similar pattern, suggesting that the difference in in vivo radioprotection among the three PROXYLs is due to the difference in their distribution to bone marrow. In general, the radioprotection provided by stable nitroxides is affected not only by redox potential and reactivity in vitro but also by pharmacokinetics. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1170 / 1178
页数:9
相关论文
共 29 条
[1]
In vivo radioprotection of mice by 3-methyl-1-phenyl-2-pyrazolin-5-one (Edaravone; Radicut®), a clinical drug [J].
Anzai, K ;
Furuse, M ;
Yoshida, A ;
Matsuyama, A ;
Moritake, T ;
Tsuboi, K ;
Ikota, N .
JOURNAL OF RADIATION RESEARCH, 2004, 45 (02) :319-323
[2]
Assessment of ESR-CT imaging by comparison with autoradiography for the distribution of a blood-brain-barrier permeable spin probe, MC-PROXYL, to rodent brain [J].
Anzai, K ;
Saito, K ;
Takeshita, K ;
Takahashi, S ;
Miyazaki, H ;
Shoji, H ;
Lee, MCI ;
Masumizu, T ;
Ozawa, T .
MAGNETIC RESONANCE IMAGING, 2003, 21 (07) :765-772
[3]
The effects of nitroxide radicals on oxidative DNA damage [J].
Damiani, E ;
Kalinska, B ;
Canapa, A ;
Canestrari, S ;
Wozniak, M ;
Olmo, E ;
Greci, L .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 28 (08) :1257-1265
[4]
LATERAL DIFFUSION IN SPIN-LABELED PHOSPHATIDYLCHOLINE MULTILAYERS [J].
DEVAUX, P ;
MCCONNEL.HM .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1972, 94 (13) :4475-&
[5]
ELECTROCHEMISTRY AND SPECTROELECTROCHEMISTRY OF NITROXYL FREE-RADICALS [J].
FISH, JR ;
SWARTS, SG ;
SEVILLA, MD ;
MALINSKI, T .
JOURNAL OF PHYSICAL CHEMISTRY, 1988, 92 (13) :3745-3751
[6]
Gilbert DL, 2000, ANN NY ACAD SCI, V899, P1
[7]
In vivo radioprotection and effects on blood pressure of the stable free radical nitroxides [J].
Hahn, SM ;
DeLuca, AM ;
Coffin, D ;
Krishna, CM ;
Mitchell, JB .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 42 (04) :839-842
[8]
Evaluation of tempol radioprotection in a murine tumor model [J].
Hahn, SM ;
Sullivan, FJ ;
DeLuca, AM ;
Krishna, CM ;
Wersto, N ;
Venzon, D ;
Russo, A ;
Mitchell, JB .
FREE RADICAL BIOLOGY AND MEDICINE, 1997, 22 (07) :1211-1216
[9]
IDENTIFICATION OF NITROXIDE RADIOPROTECTORS [J].
HAHN, SM ;
WILSON, L ;
KRISHNA, CM ;
LIEBMANN, J ;
DEGRAFF, W ;
GAMSON, J ;
SAMUNI, A ;
VENZON, D ;
MITCHELL, JB .
RADIATION RESEARCH, 1992, 132 (01) :87-93
[10]
HAHN SM, 1992, CANCER RES, V52, P1750